Prostate cancer and PSA screening

Prostate cancer is one of the most common cancers affecting men worldwide, particularly those over the age of 50. The prostate is a small gland located below the bladder that plays a role in producing seminal fluid. While many prostate cancers grow slowly and may never cause serious harm, others can be aggressive and life-threatening, which makes early detection an important part of men’s health care.

One of the main tools used to screen for prostate cancer is the Prostate-Specific Antigen (PSA) test. PSA is a protein produced by both normal and cancerous prostate cells and is measured through a simple blood test. Elevated PSA levels can indicate prostate cancer, but they can also be caused by non-cancerous conditions such as benign prostatic hyperplasia (BPH), prostatitis, infections, or even recent physical activity involving the prostate.

PSA screening has benefits and limitations. On the positive side, it can help detect prostate cancer at an early stage, when treatment is more likely to be successful. Early detection may reduce the risk of advanced disease and related complications.

However, PSA testing is not a perfect test. It can lead to false-positive results, causing unnecessary anxiety and additional procedures like biopsies. It may also detect slow-growing cancers that would never have caused symptoms, potentially leading to overtreatment and side effects such as urinary incontinence or erectile dysfunction.

Because of these factors, many health organizations recommend shared decision-making when it comes to PSA screening. Men, particularly those aged 50 to 69 or those at higher risk (such as men with a family history of prostate cancer or African ancestry), should discuss the potential benefits and risks of PSA testing with their healthcare provider.

In conclusion, prostate cancer screening using PSA testing can be a valuable tool when used thoughtfully. Informed discussions and individualised decisions are key to balancing early detection with the risks of overdiagnosis and overtreatment.

Mr Ameen currently practises and offers consultations at the Chase Lodge Hospital, so make sure to visit their homepage on the Top Doctors UK site and schedule in an appointment with Mr Ameen.